New Zealand markets closed

Lixte Biotechnology Holdings, Inc. (LIXT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.4604+0.0504 (+2.09%)
At close: 04:00PM EDT
2.2000 -0.26 (-10.58%)
After hours: 05:04PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
4,203
5,353
4,824
5,069
Total cash
4,203
5,353
4,824
5,069
Other current assets
-
10.38
10.249
15
Total current assets
4,309
5,561
5,093
5,228
Non-current assets
Total non-current assets
0
0
0
0
Total assets
4,309
5,561
5,093
5,228
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
120.508
183.752
225.965
190.292
Accrued liabilities
-
-
-
10.467
Deferred revenues
157.1
165.022
76.961
15.765
Total current liabilities
313.858
395.756
302.926
216.524
Non-current liabilities
Total non-current liabilities
0
0
0
0
Total liabilities
313.858
395.756
302.926
216.524
Stockholders' equity
Common stock
3,500
3,500
3,501
3,501
Retained earnings
-48,482
-43,395
-37,082
-30,354
Total stockholders' equity
3,995
5,165
4,790
5,012
Total liabilities and stockholders' equity
4,309
5,561
5,093
5,228